R01 Capital Manager LLC — SEC Form 4 filings
SEC reporting owner CIK 2091724. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2025-10-20 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 24,720 shares, $26,945 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 24,720 shares @ $1.09 ($26,945) in Stablecoin Development Corp, filed 2026-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Stablecoin Development Corp (SDEV) | 10% owner | 5 | — | 1 leg · 24,720 sh · $26,945 | 9 |
Form 4 filings — R01 Capital Manager LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | Stablecoin Development Corp (SDEV) jointly with R01 Fund LP, Kazley Michael John, R01 Capital LLC | Option exercise/expiry (X): 11,332,020 @ $0.00 · Sale (S): 24,720 @ $1.09 · Option exercise/expiry (X): 11,332,020 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Stablecoin Development Corp (SDEV) jointly with R01 Fund LP, Kazley Michael John, R01 Capital LLC | Purchase (P): 53,679,974 (derivative) @ $0.85 | EDGAR |
| 2026-04-30 | 4/A | Stablecoin Development Corp (SDEV) jointly with R01 Fund LP, Kazley Michael John, R01 Capital LLC | Conversion (C): 11,361,216 @ $0 · Purchase (P): 11,332,020 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | NovaBay Pharmaceuticals, Inc. (NBY) jointly with R01 Fund LP, Kazley Michael John, R01 Capital LLC | Conversion (C): 56,806,080 @ $0 · Purchase (P): 2,702,703 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | NovaBay Pharmaceuticals, Inc. (NBY) jointly with R01 Fund LP, R01 Capital LLC, Kazley Michael John | Grant/award (A): 220,663 (derivative) @ $0 · Grant/award (A): 134,375 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2091724 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →